ReGEN Biomedical
Biotechnology Research
Overview
ReGEN Biomedical focusses on growing large amounts of robust and reproducible small pieces of tissue (micro tissues) for toxicity- & pharma-screening. Functional micro-tissues present the next step in mimicking patient organs and represent the future of personalized medicine.
We are building expertise on how to assemble the micro-tissues into functional pieces of human organs, so-called macro-tissues. The micro tissues also serve as building blocks for RM-therapies and will be assembled into functional macro tissues.
It is the aim to fully automate all production platforms and equip these with advanced appropriate offline and inline quality control systems. The platform technology also enables this initiative to realize sales and licensing for specific drug screening opportunities and ex vivo disease models. The large-scale production is one of the foundations of the development of a new (manufacturing) industry around affordable Regenerative Medicine solutions.
EMPLOYEES
2-10 employees
FOUNDED
2021
HQ
—
TYPE
Privately Held
Location
- Street
- —
- City
- —
- Region
- —
- Postal code
- —
- Country
- —
Email patterns
See email patterns for ReGEN Biomedical
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
regenbiomedical.com is the website of ReGEN Biomedical.
What is the industry of the company?
ReGEN Biomedical (regenbiomedical.com) is in the Biotechnology Research industry.
When was the company founded?
ReGEN Biomedical (regenbiomedical.com) was founded in 2021.
How many employees does the company have?
ReGEN Biomedical (regenbiomedical.com) has 2-10 employees.
What is the company type?
The company type of ReGEN Biomedical (regenbiomedical.com) is Privately Held.
What are the social media accounts of the company?
The social media account of ReGEN Biomedical (regenbiomedical.com) is LinkedIn.
Social media